Muscarinic acetylcholine receptor
FunctionMuscarinic acetylcholine receptors (mAChR) contain 5 subtypes M1-M5. Subtypes M1, M3, M5 activate phospholipase C which leads to activation of protein kinase C. M2 and M4 inhibit adenylyl cyclase activity and activate G protein-gated potassium channels[1]. mAChRs belong to the family of rhodopsin-like G protein coupled seven transmembrane helix receptors and perform various non-neuronal functions[2]. DiseasemAChR M1 agonists are developed for treatment of Alzheimer disease[3]. M2 antagonists are developed for treatment of Alzheimer disease and M3 antagonists for treatment of overactive bladder and chronic obstructive pulmonary disease[4] Structural highlightsAntagonists bind to mAChR M2 at the tyrosine lid. The antagonist interacts with protein residues D103, Y104, S107, Y403 and N404[5]. See also:
| ||||||||||||
3D Structures of muscarinic acetylcholine receptors
Updated on 05-January-2026
- Muscarinic acetylcholine receptor M1
- G protein-coupled receptor – hAChR M1 (mutant) + guanine nucleotide-binding protein + scFv + transducing b chain 1 – human – Cryo EM
- Receptor – hAChR M1 (mutant) + flag peptide + tiotropium
- Transmembrane (cell surface) receptors – hAChR M1/endolysin + muscarinic toxin 7
- Tiotropium bromide, 6zg4, 6zg9 – hAChR M1 (mutant)/endolysin + agonist
- 9jea, 9uaz – hAChR M1 + atropine – Cryo EM
- 9uap – hAChR M1 + guanine nucleotide-binding protein subunit alpha-11 – Cryo EM
- 9ucp – hAChR M1 + guanine nucleotide-binding protein subunit alpha-11 + nanobody + iperoxo – Cryo EM
- G protein-coupled receptor – hAChR M1 (mutant) + guanine nucleotide-binding protein + scFv + transducing b chain 1 – human – Cryo EM
- Muscarinic acetylcholine receptor M2
- 3uon, 5yc8, 5zk3, 5zk8, 5zkb, 5zkc – hAChR M2 (mutant) + antagonist
- 4mqs – hAChR M2 (mutant) + nanobody + iperoxo
- 4mqt – hAChR M2 (mutant) + nanobody + iperoxo + modulator
- 6oik – hAChR M2 (mutant) + guanine nucleotide-binding protein + antibody fragment + transducing b chain 1 – Cryo EM
- 8j8r, 8j97, 8jaf – hAChR M2 + antibody + arrestin – Cryo EM
- 6u1n – hAChR M2/V2R + antibody + arrestin – Cryo EM
- 7t8x, 7t90 – hAChR M2 + guanine nucleotide-binding protein + scFv + acetylcholine – Cryo EM
- 7t94 – hAChR M2 + guanine nucleotide-binding protein + scFv + acetylcholine + modulator + pyridine derivative – Cryo EM
- 1a11 – rAChR M2 transmembrane domain – rat - NMR
- 3uon, 5yc8, 5zk3, 5zk8, 5zkb, 5zkc – hAChR M2 (mutant) + antagonist
- Muscarinic acetylcholine receptor M3
- 8ea0 – hAChR M3 + agonist – Cryo EM
- 8e9y – hAChR M3 + guanine nucleotide-binding protein + scFv + agonist – Cryo EM
- 8e9z – hAChR M3 + guanine nucleotide-binding protein + scFv + agonist + cholesterol – Cryo EM
- 8e9w – hAChR M3 + guanine nucleotide-binding protein + scFv + piperazine derivative – Cryo EM
- 4daj – rAChR M3
- 4u14, 4u15 – rAChR M3 + tiotropium
- 4u16, 5zhp – rAChR M3 + inhibitor
- 8ea0 – hAChR M3 + agonist – Cryo EM
- Muscarinic acetylcholine receptor M4
- 5dsg – hAChR M4 + tiotropium
- 6kp6 – hAChR M4 (mutant)
- 6d9h, 7ld4 – hAChR M4/adenosine receptor+ guanine nucleotide-binding protein + agonist – Cryo EM
- 7ld3 – hAChR M4/adenosine receptor+ guanine nucleotide-binding protein + ligand – Cryo EM
- 7v69 – hAChR M4 + guanine nucleotide-binding protein + scFv – Cryo EM
- 7trk – hAChR M4 + guanine nucleotide-binding protein + scFv + agonist – Cryo EM
- 7trs – hAChR M4 + guanine nucleotide-binding protein + scFv + acetylcholine – Cryo EM
- 7trq – hAChR M4 + guanine nucleotide-binding protein + scFv + agonist + modulator – Cryo EM
- 7v6a – hAChR M4 + guanine nucleotide-binding protein + scFv + piperidine derivative – Cryo EM
- 8fx5 – hAChR M4 + guanine nucleotide-binding protein + scFv + drug – Cryo EM
- 9kwx, 9kzk – hAChR M4/anaphylatoxin + guanine nucleotide-binding protein + scFv + anaphylatoxin – Cryo EM
- 9kv6, 9kv8 – hAChR M4/anaphylatoxin + guanine nucleotide-binding protein + scFv + VGF peptide – Cryo EM
- 9l0h – hAChR M4/anaphylatoxin + guanine nucleotide-binding protein + scFv – Cryo EM
- 9kx6 – hAChR M4/anaphylatoxin + guanine nucleotide-binding protein + complement C5 + scFv – Cryo EM
- 9umj, 9umx – hAChR M4/anaphylatoxin + guanine nucleotide-binding protein + EP54 ligand + scFv – Cryo EM
- 9umr – hAChR M4/anaphylatoxin + guanine nucleotide-binding protein + C5A-PEP ligand + scFv – Cryo EM
- 9kug, 9kxs, 9kz2, 9kz8 – hAChR M4/anaphylatoxin + guanine nucleotide-binding protein + EP67 ligand + scFv – Cryo EM
- 9kut – hAChR M4/anaphylatoxin + guanine nucleotide-binding protein + JR14a + scFv – Cryo EM
- 9kwg – hAChR M4/anaphylatoxin + guanine nucleotide-binding protein + anaphylatoxin + scFv – Cryo EM
- 9kvp – hAChR M4/anaphylatoxin + guanine nucleotide-binding protein + ligand + scFv – Cryo EM
- 9iqs – hAChR M4/cytochrome b562 + muscarinic toxin 3 – Cryo EM
- 7t96, 7trp – hAChR M4 + guanine nucleotide-binding protein + scFv + acetylcholine + modulator + pyridine derivative – Cryo EM
- 7v68 – hAChR M4 + guanine nucleotide-binding protein + scFv + agonist + modulator + pyridine derivative – Cryo EM
- 8e9x – hAChR M4 (mutant) + guanine nucleotide-binding protein + scFv + agonist – Cryo EM
- 5dsg – hAChR M4 + tiotropium
- Muscarinic acetylcholine receptor M5